Upstart: Strong Buy Call Meets Cautious DeepValue Report

What happened

A Seeking Alpha article declares Upstart a 'Strong Buy' citing a 61% surge in Q1 transaction volumes to $3.4B and a 44% revenue increase, arguing the stock trades at a 44% discount to fintech peers and a 54% discount to its 3-year average P/E. However, the latest DeepValue master report maintains a 'WAIT' rating, emphasizing that the company ended FY2025 with $985M in loans on its balance sheet and required a warehouse covenant waiver in January 2026. The report warns that the bull case hinges on continued third-party funding absorption and avoidance of further covenant breaches, with a bear scenario valuing the stock at $24 if funding tightens. Meanwhile, the article's optimism assumes Fed rate cuts will unlock revaluation, but the DeepValue analysis points to elevated credit risk (UMI ~1.39) and a multi-year regulatory timeline for the bank charter. The tension between strong operational momentum and persistent funding fragility defines the current investment setup.

Implication

The bullish article highlights impressive volume growth and a compelling valuation, but the DeepValue report correctly identifies that UPST's equity remains a high-beta credit vehicle with limited downside protection. The key risk is that the company's marketplace model converts into a levered credit book if funding channels weaken, as evidenced by the recent covenant waiver. While the bank charter effort is a potential long-term fix, it is a multi-year process with no near-term earnings impact. The attractive entry point suggested in the DeepValue report ($28) provides a margin of safety, while the current price ($34.40) leaves little room for error. A prudent approach is to wait for two consecutive quarters of declining balance-sheet loans and no further covenant breaches before establishing a position.

Thesis delta

The primary thesis shift is from expecting an immediate revaluation based on growth and macro tailwinds to requiring proven funding stability and credit performance. The bullish article's narrative of a cheap stock poised for a rebound is challenged by the DeepValue report's evidence of structural funding fragility and covenant risk. Until management demonstrates consistent third-party absorption and a clear path to reducing balance-sheet exposure, the equity lacks the margin of safety to warrant a buy rating.